Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United... see more

Recent & Breaking News (TSXV:MPH)

Dr. Albert D. Friesen to File Early Warning Report

Marketwired November 5, 2014

Medicure Reports Financial Results for the First Quarter Fiscal 2015

Marketwired October 16, 2014

Medicure Reports Financial Results for Fiscal 2014

Marketwired September 10, 2014

Medicure Provides Update on Tardoxal and TEND-TD Study

Marketwired August 13, 2014

Medicure Announces Shares for Debt Settlement

Marketwired July 11, 2014

Medicure Announces Grant of Options

Marketwired July 7, 2014

Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore

Marketwired July 3, 2014

Medicure (V.MPH) snags industry expert advisor and investors smell acquisition, up 26%

Gaalen Engen April 15, 2014

Medicure Comments on Recent Trading Activity

Marketwired April 15, 2014

Medicure Comments on Recent Trading Activity

Marketwired April 15, 2014

Medicure Engages Knight Therapeutics Inc. to Provide Advisory Services

Marketwired April 14, 2014

Medicure Reports Financial Results for the Third Quarter Fiscal 2014

Marketwired March 26, 2014

Medicure Reports Financial Results for the Third Quarter Fiscal 2014

Marketwired March 26, 2014

Medicure Reports Second Quarter Financial Results for Fiscal 2014

Marketwired January 28, 2014

Medicure Reports First Quarter Financial Results for Fiscal 2014

Marketwired October 30, 2013

IIROC Trade Resumption - Medicure Inc.

Newsfile October 11, 2013

IIROC Trading Resumption - MPH

Canada NewsWire October 11, 2013

Medicure Announces Approval of Recommended Dosing Regimen for AGGRASTAT(R)

Marketwired October 11, 2013

IIROC Trading Halt - MPH

Canada NewsWire October 11, 2013

IIROC Trade Halt - Medicure Inc.

Newsfile October 11, 2013